APC anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2_APC_073012
C57BL/6 mouse splenocytes were stained with CD3 (clone 17A2) APC (filled histogram) or rat IgG2b, κ isotype control (open histogram).
  • 17A2_APC_073012
    C57BL/6 mouse splenocytes were stained with CD3 (clone 17A2) APC (filled histogram) or rat IgG2b, κ isotype control (open histogram).
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
100235 25 µg 27€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100236 100 µg 62€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References

(PubMed link indicates BioLegend citation)
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  2. Liu J, et al. 2019. Immunity. 50:600. PubMed
  3. Rivas MA, et al. 2021. Nat Immunol. 22:240. PubMed
  4. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  5. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  6. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  7. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  8. Calabrese DR, et al. 2020. J Clin Invest. . PubMed
  9. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  10. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  11. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  12. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  13. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  14. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  15. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  16. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  17. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  18. Fu X, et al. 2020. J Immunol. 205:2066. PubMed
  19. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  20. Baram T, et al. 2021. Cells. 10:. PubMed
  21. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  22. Pessoa Rodrigues C, et al. 2021. Sci Adv. 7:. PubMed
  23. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  24. Sano T, et al. 2021. Cell Reports. 36:109608. PubMed
  25. Yamamoto R et al. 2018. Cell stem cell. 22(4):600-607 . PubMed
  26. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  27. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  28. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  29. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  30. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  31. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  32. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  33. Fujino T, et al. 2021. Nat Commun. 12:1826. PubMed
  34. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  35. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
  36. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  37. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  38. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  39. Thomas S, et al. 2019. J Immunother Cancer. 7:214. PubMed
  40. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  41. Zhang X, et al. 2022. Pharmaceutics. 14:. PubMed
  42. Tang D, et al. 2020. Br J Haematol. 191:906. PubMed
  43. van Elsas MJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  44. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  45. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  46. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  47. Wu G, et al. 2020. Br J Pharmacol. 177:5063. PubMed
  48. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  49. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  50. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  51. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  52. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  53. Li X, et al. 2020. Mol Ther. 28:2430. PubMed
  54. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  55. Ren HZ, et al. 2022. J Clin Transl Hepatol. 10:1138. PubMed
  56. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  57. Hiramoto T, et al. 2018. Mol Ther. 26:1255. PubMed
  58. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  59. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  60. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  61. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  62. Utley A, et al. 2020. Cell Rep. 31:107815. PubMed
  63. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  64. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  65. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  66. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  67. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  68. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  69. Court AC, et al. 2020. EMBO Rep. 21:e48052. PubMed
  70. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  71. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  72. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  73. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  74. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  75. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  76. Liu Y, et al. 2017. Oncogene. 10.1038/onc.2017.209. PubMed
  77. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  78. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  79. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  80. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  81. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  82. Wang Y, et al. 2021. Front Microbiol. 12:701566. PubMed
  83. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  84. Tomala J, et al. 2020. Methods Mol Biol. 2111:101. PubMed
  85. Wen M, et al. 2022. JCI Insight. Online ahead of print. PubMed
  86. Stirling ER, et al. 2022. J Immunother Cancer. 10:. PubMed
  87. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  88. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  89. Xiong W, et al. 2022. Adv Sci (Weinh). 9:e2103029. PubMed
  90. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  91. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  92. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  93. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  94. Xi‐Zhi J Guo et al. 2018. Immunity. 49(3):531-544 . PubMed
  95. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  96. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  97. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  98. Martinez-Turtos A, et al. 2022. Oncoimmunology. 11:2116844. PubMed
  99. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  100. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  101. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  102. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  103. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  104. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  105. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  106. Zhang J, et al. 2018. Nature. 553:91. PubMed
  107. Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed
  108. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  109. Olivo Pimentel V, et al. 2021. J Immunother Cancer. 9:. PubMed
  110. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  111. Adnan-Awad S, et al. 2020. Leukemia. . PubMed
  112. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  113. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  114. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  115. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  116. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  117. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  118. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  119. Liu P, et al. 2020. Mol Cell. 748:77. PubMed
  120. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  121. Olson CA, et al. 2021. Cell Host Microbe. 29:1378. PubMed
  122. Kim S, et al. 2020. Autophagy. :1. PubMed
  123. Lazarian G, et al. 2021. Cancer Cell. 39(3):380-393.e8. PubMed
  124. Yoshida S, et al. 2022. PLoS One. 17:e0264317. PubMed
  125. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  126. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  127. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  128. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  129. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  130. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  131. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  132. Arora S, et al. 2021. Med (N Y). 2:938. PubMed
  133. Li H, et al. 2022. iScience. 25:104481. PubMed
  134. Wang Y, et al. 2021. Cell Reports. 36(6):109516. PubMed
  135. Agelidis A, et al. 2017. Cell Rep. 10.1016/j.celrep.2017.06.041. PubMed
  136. Sartorius R, et al. 2018. Front Immunol. 1.413888889. PubMed
  137. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  138. Lightman SM, et al. 2020. Cell Reports. 1.086805556. PubMed
  139. Kujur W, et al. 2020. PLoS Pathog. 16:e1009132. PubMed
  140. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  141. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  142. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  143. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  144. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  145. Zeng A, et al. 2020. Oncol Rep. . PubMed
  146. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  147. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  148. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  149. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  150. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  151. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  152. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  153. Lake CM, et al. 2021. Cell Death Dis. 12:400. PubMed
  154. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
RRID
AB_2561455 (BioLegend Cat. No. 100235)
AB_2561456 (BioLegend Cat. No. 100236)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
FITC anti-mouse CD3 17A2 FC
PE anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Alexa Fluor® 647 anti-mouse CD3 17A2 FC,IHC-F,3D IHC,SB
Alexa Fluor® 488 anti-mouse CD3 17A2 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC,ICC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F,FC,3D IHC,SB
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
Biotin anti-mouse CD3 17A2 FC,IHC-F
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
Spark NIR™ 685 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
APC/Fire™ 810 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
PE/Fire™ 700 anti-mouse CD3 17A2 FC
PE/Cyanine5 anti-mouse CD3 17A2 FC
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Spark UV™ 387 anti-mouse CD3 17A2 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account